{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:47:47Z","timestamp":1794638867593,"version":"4.9.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.leukres.2007.07.016","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T11:24:06Z","timestamp":1188991446000},"page":"379-382","source":"Crossref","is-referenced-by-count":45,"title":["CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis"],"prefix":"10.1016","volume":"32","author":[{"given":"R\u00e9gis","family":"Bataille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pellat-Deceunynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Robillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Avet-Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Harousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.07.016_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","article-title":"KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation","volume":"13","author":"Miettinen","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.leukres.2007.07.016_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.1996.tb08993.x","article-title":"Expression of the CD117 antigen (c-kit) on normal and myelomatous plasma cells","volume":"95","author":"Ocqueteau","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2007.07.016_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.07.016_bib4","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double transplant in myeloma: a randomised trial of the IFM","volume":"349","author":"Attal","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.07.016_bib5","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1182\/blood-2004-12-4700","article-title":"Phenotypic characterization of the human myeloma cell growth fraction","volume":"105","author":"Robillard","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.07.016_bib6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2002-11-3333","article-title":"The expression of CD20 is aberrant, significantly associated with a small mature plasma-cell morphology, t(11;14) and good survival in multiple myeloma","volume":"102","author":"Robillard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.07.016_bib7","first-page":"706","article-title":"CD221 (IGF1-R) is aberrantly expressed in multiple myeloma, in relation to disease severity","volume":"90","author":"Bataille","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.07.016_bib8","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.07.016_bib9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","article-title":"Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive therapy","volume":"100","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.07.016_bib10","first-page":"1655","article-title":"Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma","volume":"152","author":"Ocqueteau","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2007.07.016_bib11","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1080\/1042819021000040198","article-title":"Immunohistochemical identification of HER-2\/neu overexpression and CD117 (c-kit) expression in multiple myeloma","volume":"43","author":"Potti","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2007.07.016_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.5858\/2003-127-1596-CBNLIP","article-title":"CD117, but not lysozyme, is positive in cutaneous plasmacytoma","volume":"127","author":"Bayer-Garner","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.leukres.2007.07.016_bib13","first-page":"951","article-title":"Expression of CD117 on multiple myeloma and its significance","volume":"23","author":"Li","year":"2004","journal-title":"Ai Zheng"},{"key":"10.1016\/j.leukres.2007.07.016_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00428-003-0934-8","article-title":"Rare kit (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment","volume":"444","author":"Lugli","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.leukres.2007.07.016_bib15","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1080\/10428190412331283279","article-title":"c-Kit receptor (CD117) expression on plasma cells in monoclonal gammopathies","volume":"45","author":"Kraj","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2007.07.016_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2559.2006.02375.x","article-title":"The prevalence and clinical implications of c-kit expression in plasma cell myeloma","volume":"48","author":"Pruneri","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.leukres.2007.07.016_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10428190500271269","article-title":"A phase II trial of imatinib in patients with refractory\/relapsed myeloma","volume":"47","author":"Dispenzieri","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"S1","key":"10.1016\/j.leukres.2007.07.016_bib18","first-page":"196","article-title":"Accurate prediction of outcome for with IgG and IgA monoclonal gammopathy of unknown significance patients using flow cytometry","volume":"90","author":"Rawstron","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.07.016_bib19","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-04-1489","article-title":"Genetic abnormalities and patterns of antigenic expression in multiple myeloma","volume":"11","author":"Mateo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.07.016_bib20","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","article-title":"A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS","volume":"106","author":"Chang","year":"2005","journal-title":"Blood"},{"issue":"s1","key":"10.1016\/j.leukres.2007.07.016_bib21","first-page":"103","article-title":"Prognostic influence of antigenic markers in 587 multiple myeloma patients uniformly treated with high dose therapy","volume":"90","author":"Mateo","year":"2005","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607003013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607003013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T20:48:22Z","timestamp":1629665302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607003013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0145212607003013"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.07.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}